Donor Site Aesthetic Enhancement With Preoperative Botulinum Toxin in Forehead Flap Nasal Reconstruction

被引:31
作者
Zelken, Jonathan [1 ]
Yang, Shih-Yi [1 ]
Chang, Chun-Shin [1 ]
Chang, Cheng-Jen [1 ]
Yang, Jui-Yung [1 ]
Chuang, Shiow-Shuh [1 ]
Chen, Hung-Chang [1 ]
Hsiao, Yen-Chang [1 ]
机构
[1] Chang Gung Univ, Dept Plast & Reconstruct Surg, Chang Gung Mem Hosp, Coll Med, Taipei, Taiwan
关键词
botulinum toxin; wound; rhinoplasty; scar; forehead flap; Asian; reconstruction; CLEFT-LIP REPAIR; FACIAL WOUNDS; DEFECTS; SCARS;
D O I
10.1097/SAP.0000000000000625
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Donor site scarring after forehead flap nasal reconstruction is acceptable. However, as aesthetic outcomes standards for cosmetic and reconstructive surgery merge, we aim to enhance results. We recently demonstrated the cosmetic benefit of botulinum toxin type A (BTX-A) for cleft lip cheiloplasty outcomes. We hypothesize that similar mechanism(s) benefit forehead flap donor scars. Methods: A single surgeon performed 26 forehead flap reconstructions. Indications were cancer (n = 17), trauma (n = 3), and congenital deformity (n = 6). In this split-scar study half the forehead was pretreated with BTX-A and half with normal saline after random assignment. Photographs were evaluated at most recent follow-up. Scar evaluation was based on photographs by 3 plastic surgeons using a composite subjective visual analogue score (VAS). Results: Photographic follow-up was 27 months (range, 10-60 months). Botulinum toxin type A was assigned to the upper forehead in 16 cases and lower forehead in 10 cases. Intrarater reliability among 4 evaluators of 104 VAS scores was 78.1%. Upper forehead VAS (7.9 +/- 1.2) was not different than lower forehead VAS (7.9 +/- 1.2) regardless of treatment (P = 0.62). The VAS score of BTX-Atreated scars (8.5 +/- 1.0) was significantly higher than the control (7.3 +/- 1.1; P < 0.0001). Among 104 individual comparisons (26 patients x 4 observers), there were 73 instances (70.2%) where the experimental VAS score was higher than the control. Conclusions: Preoperative BTX-A injection is feasible and enhances donor site scar appearance after forehead flap nasal reconstruction in an Asian population.
引用
收藏
页码:535 / 538
页数:4
相关论文
共 25 条
[1]  
[Anonymous], PLAST RECONSTR SURG, DOI DOI 10.1097/PRS.0B013
[2]  
Becker G D., 1998, J WOUND CARE, V7, P497, DOI DOI 10.12968/JOWC.1998.7.10.497
[3]   Botulinum Toxin to Improve Results in Cleft Lip Repair: A Double-Blinded, Randomized, Vehicle-Controlled Clinical Trial [J].
Chang, Chun-Shin ;
Wallace, Christopher Glenn ;
Hsiao, Yen-Chang ;
Chang, Chee-Jen ;
Chen, Philip Kuo-Ting .
PLOS ONE, 2014, 9 (12)
[4]   Botulinum Toxin to Improve Results in Cleft Lip Repair [J].
Chang, Chun-Shin ;
Wallace, Christopher Glenn ;
Hsiao, Yen-Chang ;
Chang, Chee-Jen ;
Chen, Philip Kuo-Ting .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2014, 134 (03) :511-516
[5]   Use of botulinum A toxin in patients at risk of wound complications following eyelid reconstruction [J].
Choi, JC ;
Lucarelli, MJ ;
Shore, JW .
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 1997, 13 (04) :259-264
[6]  
Deutsch BD, 1997, ARCH OTOLARYNGOL, V123, P529
[7]   Different types of botulinum toxin in humans [J].
Eleopra, R ;
Tugnoli, V ;
Quatrale, R ;
Rossetto, O ;
Montecucco, C .
MOVEMENT DISORDERS, 2004, 19 :S53-S59
[8]   Use of Intraoperative Botulinum Toxin in Facial Reconstruction [J].
Flynn, Timothy Corcoran .
DERMATOLOGIC SURGERY, 2009, 35 (02) :182-188
[9]  
Galarraga Ivan Marcelo Cueva, 2009, Can J Plast Surg, V17, pe1
[10]   Treatment of facial wounds with botulinum toxin A improves cosmetic outcome in primates [J].
Gassner, HG ;
Sherris, DA ;
Otley, CC ;
Larrabee, WF .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2000, 105 (06) :1954-1955